20 articles
Engineered cerium-peptide microspheres show 76% reduction in IBD symptoms and 66% decrease in fibrosis markers in mouse studies.
A common oat fiber supercharges anti-PD-1 checkpoint therapy by expanding a key gut microbe that produces immune-activating metabolites.
New research shows how a specific gut bacteria enhances anti-PD-1 therapy effectiveness in hard-to-treat colorectal cancers.
Scientists discover how beneficial gut bacteria produce proteins that bind to inflammatory toxins, potentially reducing chronic inflammation.
A microbial enzyme from Bifidobacterium enhances anti-TNF therapy efficacy in IBD by reshaping immune regulation via histone lactylation.
Enhanced probiotic formula reduces intestinal fibrosis by boosting beneficial bile acids that calm inflammatory responses.
A receptor that keeps firing inside pain cells may explain why IBS discomfort is so persistent and hard to treat.
Study reveals how gut microbiota-derived propionic acid can restore reproductive function and reverse aging effects through gut-organ communication.
New research reveals how certain gut bacteria weaken immune responses against tumors by consuming asparagine, potentially undermining cancer treatments.
A specific gut bacterium produces deoxycholic acid that hijacks tumor immunity, offering new targets for breast cancer treatment.
New research shows blocking PKM2 in immune cells promotes gut healing in colitis while preventing tumor formation.
New research reveals how polysaccharides from goji berries combat aging through immune support and inflammation reduction.
A completed clinical trial tests whether a prebiotic blend can boost Akkermansia muciniphila and support weight management in metabolic syndrome.
Regular physical activity slashes chronic pancreatitis risk and attenuates disease progression via muscle-derived vesicles that quiet pancreatic inflammation.
Small pilot study tests whether resistant starch from potatoes can safely modify gut bacteria in cancer patients receiving dual checkpoint inhibitors.
New research reveals how gut microbiome disruption drives osteosarcopenia through inflammation and nutrient pathways.
A prospective clinical study examines how gastric bypass alters gut bacteria, appetite hormones, and metabolic health in 60 severely obese patients.
Bacterial metabolite from flavonoids protects against graft-versus-host disease while preserving anti-cancer effects in stem cell transplants.
Clinical trial tests whether fecal transplants from young, active donors can restore muscle strength and cognitive function in older adults.
A comprehensive review reveals how SCFAs, bile acids, and tryptophan metabolites reshape the tumor immune microenvironment in GI cancers.
